| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/02/2006 | EP1685101A1 N-acylated-3-(benzoyl)-pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders. |
| 08/02/2006 | EP1684793A1 Soluble pharmaceutical compositions for parenteral administration comprising a glp-1 peptide and a insulin peptide of short time action for treatment of diabetes and bulimia |
| 08/02/2006 | EP1684757A1 Substituted piperidines for the treatment of metabolic syndrome |
| 08/02/2006 | EP1684752A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 08/02/2006 | EP1684737A1 Pharmaceutical composition containing guaiacol derivatives and syringol derivatives extracted from natural plant vinegar |
| 08/02/2006 | EP1684727A1 Macromolecular drug complexes having improved stability and therapeutic use of the same |
| 08/02/2006 | EP1684593A2 Method of decreasing fat deposits and body weight in mammals and birds |
| 08/02/2006 | EP1605947B1 Use of pteridine derivatives for the treatment of increased intracranial pressure |
| 08/02/2006 | EP1561468A4 Pharmaceutical antidiabetic composition |
| 08/02/2006 | EP1532147B1 Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 08/02/2006 | EP1529043B1 Process for the preparation of 2-methyl piperazine derivatives. |
| 08/02/2006 | EP1505965B1 Use of the metabolite of valsartan to inhibit platelet aggregation |
| 08/02/2006 | EP1435971B1 Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs) |
| 08/02/2006 | EP1420815B1 Beta-amyloid-analogue - t-cell epitop vaccine |
| 08/02/2006 | EP1381614B1 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO¬2,3-f|QUINOXALINE |
| 08/02/2006 | EP1358177B1 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 08/02/2006 | EP1333887B1 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 08/02/2006 | EP1328280B1 Composition for the treatment of dysglucaemia and method for the production of said composition |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 08/02/2006 | EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 08/02/2006 | EP1263418B1 Method of preparing cartilage enhancing food supplements |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812979A Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 08/02/2006 | CN1812978A Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812812A Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 08/02/2006 | CN1812779A Compounds for treatment of inflammation, diabetes and related disorders |
| 08/02/2006 | CN1812777A Composition for lowering blood glucose |
| 08/02/2006 | CN1810797A Prepn of flavone compound with guava leaf |
| 08/02/2006 | CN1810795A Benzopyran compound and its prepn and use |
| 08/02/2006 | CN1810283A Phenformin capsule |
| 08/02/2006 | CN1810263A Quantum mediated tracking process of preparing medicine for treating diabetes |
| 08/02/2006 | CN1810238A Oral arginine prepn for preventing and treating cachexia syndrome |
| 08/02/2006 | CN1810236A Liposome preparation of garlicin |
| 08/02/2006 | CN1267727C Ginkgo leaf composition, and preparing method and use thereof |
| 08/02/2006 | CN1267561C Method of bological transforming selenium using bacillus bifidus and its product |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267456C Process for preparing glucose-reducing sand sagebrush polysaccharide and its application |
| 08/02/2006 | CN1267438C antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 08/02/2006 | CN1267434C Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene |
| 08/02/2006 | CN1267432C 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives |
| 08/02/2006 | CN1267430C Triazole compounds with dopamine -D3-receptor affinity |
| 08/02/2006 | CN1267424C Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/02/2006 | CN1267408C Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system |
| 08/02/2006 | CN1267407C Prodrugs of excitatory amino acids |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267148C Use of GnRH antagonists in prevention of diabetes by administration |
| 08/02/2006 | CN1267144C Compound diabetes-treating sugar-decreasing fat-reducing preparation and preparation method thereof |
| 08/02/2006 | CN1267114C Midicial herbal compound for prevention and treatment of diabetes |
| 08/02/2006 | CN1267100C Medicinal composition and its preparation and use |
| 08/02/2006 | CN1267098C Usage of treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 08/02/2006 | CN1267095C Application use of dihydromyricetrin |
| 08/02/2006 | CN1267090C Garlicin injection emulsion and its preparing method |
| 08/02/2006 | CN1267086C Medicine for treating diabetes and adjusting blood sugar concentration and its preparation |
| 08/02/2006 | CN1267085C Modifying the fatty acid composition of cell membranes of organs and tissues |
| 08/02/2006 | CN1267024C Tryptophan source from plants and uses therefor |
| 08/01/2006 | US7084282 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 08/01/2006 | US7084243 Glucagon-like peptide-1 analogs |
| 08/01/2006 | US7084242 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol |
| 08/01/2006 | US7084240 Crystallization of IGF-1 |
| 08/01/2006 | US7084177 Antidiabetic agents |
| 08/01/2006 | US7084172 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084143 N-(indolecarbonyl) piperazine derivatives |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084133 Reaction product of carborane and vitamin d; therapy for vitamin deficiency diseases |
| 08/01/2006 | US7084127 C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses |
| 08/01/2006 | US7084123 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/01/2006 | US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents |
| 08/01/2006 | US7084120 Prodrugs of DP IV-inhibitors |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7084114 Mixtures of insulin drug-oligomer comprising polyalkylene glycol |
| 08/01/2006 | US7084107 Methods for stabilizing liquid nutritional products and products so stabilized |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083952 Nucleotide sequences coding phosphoserine phosphatase for generation of trangenic cornyeform bacterium with enhanced serine and threonine biosynthesis; for use in preparation of food, animal feeds and/or human therapeutics |
| 08/01/2006 | US7083947 Assay techniques using nematode worms |
| 08/01/2006 | CA2395623C Inulin products with improved nutritional properties |
| 08/01/2006 | CA2340429C Trans-xanthophyll ester concentrates of enhanced purity and methods of making same |
| 08/01/2006 | CA2192456C Pyridylbisphosphonates for use as a therapeutical agent |
| 07/27/2006 | WO2006079077A2 Use of diltiazem or analogs thereof as modulators of ghrelin receptor |
| 07/27/2006 | WO2006079021A2 Use of sirtuin-activating compounds for treating flushing and drug induced weight gain |
| 07/27/2006 | WO2006078941A2 Novel sirtuin activating compounds and methods of use thereof |
| 07/27/2006 | WO2006078698A1 2-imidazolone and 2-imidazolidinone heterocyclic inhibitors of tyrosine phosphatases |
| 07/27/2006 | WO2006078600A1 Compositions containing policosanol and theaflavin and their pharmaceutical uses |
| 07/27/2006 | WO2006078037A1 Process for producing thiazolidinedione compound and production intermediate thereof |
| 07/27/2006 | WO2006078006A1 Indole compound and pharmaceutical composition containing the same |
| 07/27/2006 | WO2006077975A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 07/27/2006 | WO2006077972A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 07/27/2006 | WO2006077456A1 Oral administration of therapeutic agent coupled to transporting agent |
| 07/27/2006 | WO2006077442A2 Inhibition of islet amyloid polypeptide (iapp) aggregation for the treatment of type 2 diabetes |
| 07/27/2006 | WO2006077217A1 New 3-phenylpropionic acid derivatives |
| 07/27/2006 | WO2006077202A1 Novel nutraceutical compositions |
| 07/27/2006 | WO2006077025A2 Morpholines as 5ht2c agonists |
| 07/27/2006 | WO2006077024A2 5-aminoindole derivatives |
| 07/27/2006 | WO2006076796A1 Cathepsin k inhibitors and obesity |
| 07/27/2006 | WO2006066173A3 Novel mch receptor antagonists |